维普中文期刊产品整合服务
33篇 您的检索式:作者名="Bitzan M"
    题名 作者 年代 出处 被引量
1Treatment of typical(erteropathic) hemolytic uremic syndrome显示文摘Bitzan M Schaefer F Reymond D 2010Semin Thromb Hemost2010,36,6:1
2Rituximab ( B - cell depleting antibody) associated lung injury( RALI):A pediatric case and systematic review of the literature 显示文摘Bitzan M Anselmo M Carpineta L 2009Pediatr Pulmonol2009,44,9:1
3Treatment of typical (enteropathic) hemolytic uremic syndrome显示文摘Bitzan M Schaefer F Reymond D 2010Semin Thromb Hemost2010,36,6:1
4Cryptogenic organizing pneumoniaafter rituximab therapy for presumed post-kidney transplant lymphopro-liferative disease 显示文摘Bitzan M Ouahed JD Carpineta L 2010Pediatr Nephrol2010,25,6:1
5Treatment options for HUS secondary to Escherichia coli O157:H7显示文摘Bitzan M 2009Kidney Int Suppl2009,112,:1
6Non-enteropath- ic hemolytic uremic syndrome: causes and short- term course显示文摘Constantinescu AR Bitzan M Weiss LS 2004Am J Kidney Dis2004,43,6:1
7Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with he molyticuremic syndrome显示文摘Ludwig K Bitzan M Zimmermann S 1996J Infect Dis1996,174,:1
8Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with he molyticuremic syndrome显示文摘Ludwig K Bitzan M Zimmermann S 1996J Infect Dis1996,174,:1
9Rituximab (B-cell depleting antibody) associated lung injury(RALI):a pediatric case and systematic review of the literature显示文摘Bitzan M Anselmo M Carpineta L 0,,09:1
10Management of hemolytic uremic syndrome显示文摘Loirat C Saland J Bitzan M 2012Presse Med2012,41,32:1
11Rituximab (B-cell depleting antibody) associated lung injury (RALI):a pediatric case and systematic review of the literature显示文摘Bitzan M Anselmo M Carpineta L 2009Pediatr Pulmonol2009,44,:1
12Rituximab(B-cell depleting antibody) associated lung injury(RALI)a pediatric case and systematic review of the literature显示文摘Bitzan M Anselmo M Carpineta L 2009Pediatr Pulmonol2009,44,9:1
13Analysis of genes encoding laminin β2 and related proteins in patients with Galloway-Mowat syndrome显示文摘Dietrich A Matejas V Bitzan M 2008Pediatr Nephrol2008,23,:1
14The role of antibiotics in the management of verotoxin-associated hemolytic anemia syndromes显示文摘Bitzan M Muller-Wiefel DE Schwarzkopf A 1992Immun Infekt1992,20,5:1
15Non-enteropathie hemolytic uremie syndrome:Causes and short-term course显示文摘Constantineseu AR Bitzan M Weiss LS Christen E Kaplan BS Cnaan A 2004Am J Kidney Dis2004,436,:1
16Non-enteropathic hemo-lytic uremic syndrome:Causes and short-term course显示文摘Constantinescu AR Bitzan M Weiss LS 0,,:1
17Shiga Toxin-Producing Escherichia Coli Infection and Antibodies Against stx2 and stx1 in Household Contacts of Children with Enteropathie Hemolytic-Uremic Syndrome显示文摘 Sarkim V Bitzan M 2002J Clin Microbiol2002,40,5:1
18Treatment options for HUS secondary to Escherichia coli O157:H7显示文摘Bitzan M 2009Kidney Int Suppl2009,75,:1
19TNFalpha pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and beta3 integrin activation 显示文摘Bitzan M Babayeva S Vasudevan A 2012Pediatr Ncphrol2012,27,12:1
20Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Nephrotic Syndrome in Children显示文摘Samuel S Bitzan M Zappitelli M 2014Am J Kidney Dis2014,63,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费